Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
156.92
-1.81 (-1.14%)
Apr 29, 2026, 11:04 AM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.17 billion as of April 29, 2026. Its market cap has increased by 237.86% in one year.
Market Cap
6.17B
Enterprise Value
5.75B
1-Year Change
237.86%
Ranking
Category
Stock Price
$156.92
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.17B, an increase of 4,170.00%. That is a compound annual growth rate of 155.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.24B | 4.06% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.75B |
| Protagonist Therapeutics | 6.46B |
| Apogee Therapeutics | 6.30B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 5.92B |
| Cogent Biosciences | 5.85B |
| PTC Therapeutics | 5.83B |